FDA Announces Recall of Allergy Tablets Due to Contamination Concerns

The U.S. Food and Drug Administration has issued a voluntary recall for specific lots of 5-milligram cetirizine hydrochloride tablets, a common antihistamine. This action follows the discovery of potential cross-contamination with ranitidine, a medication for heartburn, during manufacturing. The recall was initiated after unusual tablet appearance was noted, confirming a manufacturing issue by an India-based company distributing nationwide.